TARO PHARMACEUTICAL INDUS (TARO) Stock News
NYSE:TARO - New York Stock Exchange, Inc. - IL0010827181 - Common Stock - Currency: USD
TARO Latest News, Press Relases and Analysis
TARO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Taro Pharmaceutical Industries Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
TARO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Taro Pharmaceutical Industries Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
/PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has...
TARO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Taro Pharmaceutical Industries Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Sun Pharma Completes Taro Merger
/PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715 (together with its subsidiaries and/or...
Taro Shareholders Approve Merger with Sun Pharma
/PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or...
TARO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Taro Pharmaceutical Industries Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
/PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has...
Ademi LLP announces the filing of Class Action Lawsuit against Taro Pharmaceutical Industries Ltd. and other Defendants
/PRNewswire/ -- Ademi LLP announces that a class action lawsuit has been filed on September 9, 2024 in the United States District Court for the Southern...
TARO Stock Earnings: Taro Pharmaceutical Indus Reported Results for Q4 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Taro Pharmaceutical Indus (NYSE:TARO) just reported results for the fourth quar...
TARO Stock Earnings: Taro Pharmaceutical Indus Reported Results for Q4 2024
Taro Pharmaceutical Indus just reported results for the fourth quarter of 2024.
Taro Provides Results for Year Ended March 31, 2024
Krensavage Asset Management Remains Opposed to Sun's Predatory Bid for Taro
/PRNewswire/ -- Krensavage Asset Management today sent the following message to a special committee evaluating Sun Pharmaceutical Industries Ltd.'s bid for...
Taro Announces Merger Agreement with Sun Pharma
/PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or...
Shareholder Alert: Ademi LLP investigates whether Taro Pharmaceutical Industries Limited has obtained a Fair Price for its Public Shareholders in its transaction with its majority shareholder, Sun Pharmaceutical Industries Limited.
/PRNewswire/ -- Ademi LLP is investigating Taro (NYSE: TARO) for possible breaches of fiduciary duty and other violations of law in its transaction with its...
Taro to Release Full Year Results on May 20, 2024
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote “FOR” Taro Sun Pharma Merger
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TARO, HES, ANSS
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.
Kuehn Law Encourages PGTI, TAST, TARO, and ANSS Investors to Contact Law Firm
/PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law...
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates ANSS, TARO, MDC
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Taro Provides Results for December 31, 2023
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates TAST, MDC, TARO, SOLO
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Taro to Release Third Quarter Results on January 25, 2024
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates TARO, MDC, PGTI, VIA
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Sun Pharma to take Taro private for $43 per share (NYSE:TARO)
Taro Pharmaceutical Industries (TARO) said it has agreed to be taken private by controlling shareholder Sun Pharmaceutical Industries for $43 a share. Read more here.
Taro Pharmaceutical GAAP EPS of $0.23, revenue of $148.2M (NYSE:TARO)
Taro Pharmaceutical press release (NYSE:TARO): Q2 GAAP EPS of $0.23.Revenue of $148.2M (+13.6% Y/Y).Research and development (R&D) expenses of $14.3...